PT-141 doesnt require baseline labs to start
In a pre-specified blinded extension, 532 participants with a baseline BMI of 35 or higher who continued on retatrutide through 104 weeks lost an average of 85 lbs, or 30.3% of body weight a figure that for the first time brings a pharmacological agent into direct numerical parity with sleeve gastrectomy and gastric bypass outcomes
Adams DW, Moleski S, Jossen J, Tye-Din JA (2024) Clinical presentation and spectrum of gluten symptomatology in celiac disease
This accidental discovery set off decades of research that transformed the compound into injectable medications
Frequently asked questions The Alloy Promise At Alloy Health, we believe every woman deserves thoughtful, evidence-based care, and the information she needs to make confident decisions about her health based on facts, not fear